ndia Strengthens Global Pharma Position with Ambitious Export Target

India has set an ambitious target of increasing pharmaceutical exports to $50 billion (₹4.76 lakh crore) by 2030, according to Commerce Ministry Deputy Director D. Raviteja. He stated that pharma exports have grown at an average annual rate of 7.22% over the past 12 years, rising from $14 billion in 2014 to $31 billion in 2025–26.

India currently ranks third globally in pharmaceutical production and seventh in sales, supplying around 20% of the world’s generic medicines. The United States accounts for 34% of India’s pharma exports, while Europe contributes 19%. The government has also extended customs duty exemptions on 40 key raw materials to ease supply chain pressures and reduce production costs. Telangana alone contributes nearly 35–40% of India’s pharma exports, with Hyderabad serving as a major hub.